Compare BEAM & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAM | CLBK |
|---|---|---|
| Founded | 2017 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2019 | 2026 |
| Metric | BEAM | CLBK |
|---|---|---|
| Price | $23.08 | $11.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $49.85 | $14.17 |
| AVG Volume (30 Days) | 1.8M | ★ 3.0M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $24,000.00 | N/A |
| Revenue This Year | N/A | $62.85 |
| Revenue Next Year | N/A | $43.10 |
| P/E Ratio | ★ N/A | $80.43 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $20.23 | $10.51 |
| 52 Week High | $38.26 | $25.83 |
| Indicator | BEAM | CLBK |
|---|---|---|
| Relative Strength Index (RSI) | 40.33 | 53.51 |
| Support Level | $22.65 | $10.61 |
| Resistance Level | $28.19 | $11.86 |
| Average True Range (ATR) | 1.92 | 0.28 |
| MACD | -0.33 | 0.06 |
| Stochastic Oscillator | 0.07 | 73.22 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.